Emerging Global Leader Award (K43 Independent Clinical Trial Required)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Dec 3, 2026
- Who can apply
- Others (see notice)
Assistance Listing 93.838
Department of Health and Human Services · National Institutes of Health
Assistance Listing 93.838, “Lung Diseases Research,” is a federal program administered by Department of Health and Human Services. It provides grant and cooperative agreement assistance. GrantsJunction currently tracks 73 open, 5 forecasted and 4 closed opportunities under this listing. The agency reported $789M in obligations for fiscal year 2025.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The Division of Lung Diseases supports research and research training on the causes, diagnosis, prevention, and treatment of lung diseases and sleep disorders. Research is funded through investigator-initiated and Institute-initiated grant programs and through contract programs in areas including asthma, bronchopulmonary dysplasia, chronic obstructive pulmonary disease, cystic fibrosis, respiratory neurobiology, sleep and circadian biology, sleep-disordered breathing, critical care and acute lung injury, developmental biology and pediatric pulmonary diseases, immunologic and fibrotic pulmonary disease, rare lung disorders, pulmonary vascular disease, and pulmonary complications of AIDS and tuberculosis. The Division is responsible for monitoring the latest research developments in the extramural scientific community as well as identifying research gaps and needs, obtaining advice from experts in the field, and implementing programs to address new opportunities. Small Business Innovation Research (SBIR) program: To stimulate technological innovation; use small business to meet Federal research and development needs; foster and encourage participation in innovation and entrepreneurship by socially and economically disadvantaged persons; and increase private-sector commercialization of innovations derived from Federal research and development funding. Small Business Technology Transfer (STTR) program: To stimulate technological innovation; foster technology transfer through cooperative R&D between small businesses and research institutions, and increase private sector commercialization of innovations derived from federal R&D.
As published in the SAM.gov Assistance Listing.
Any nonprofit organization engaged in biomedical research and institutions or companies organized for profit may apply for almost any kind of grant. Only domestic, non-profit, private or public institutions may apply for NRSA Institutional Research Training Grants. An individual may apply for an NRSA or, in some cases, for a research grant if adequate facilities to perform the research are available. SBIR grants can be awarded only to United States small business concerns (entities that are independently owned and operated for profit or owned by another small business that itself is independently owned and operated for profit, or owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these and have no more than 500 employees including affiliates). Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project. In both Phase I and Phase II, the research must be performed in the U.S. or its possessions except under rare and unique circumstances where foreign components are thoroughly justified and necessary to the overall completion of the project. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council. Normally, SBIR projects must be performed at least 67% by the applicant small business in Phase I and at least 50% of the Project in Phase II. STTR grants can be awarded only to United States small business concerns (entities that are independently owned and operated for profit and have no more than 500 employees) that formally collaborate with a university or other non-profit research institution in cooperative research and development. The principal investigator of an STTR award may be employed with either the small business concern or collaborating non-profit research institution as long as s/he has a formal appointment with or commitment to the applicant small business concern and is willing to devote at least 10% effort (1.2 calendar months) to the project. At least 40% of the project is to be performed by the small business concern and at least 30% by the non-profit research institution. In both Phase I and Phase II, the research must be performed in the U.S. and its possessions except under rare and unique circumstances where foreign components are thoroughly justified and necessary to the overall completion of the project.
Intended beneficiaries: For-Profit Organization, Unrestricted by Individual Type and Nonprofit Organization.
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Range and average of financial assistance (from the listing): Grants: 4,480 to $4,545,822; $542,589. SBIR Phase I-- $294,551, Phase II- $931,788; STTR Phase I- $265,043, Phase II- $872,004.
Source: SAM.gov Assistance Listing 93.838. Hatched bars are agency estimates. These totals do not indicate approval rates.| Opportunity | Status | Award range | Closes | ALN |
|---|---|---|---|---|
| Closed | Up to $1.5M | Sep 30, 2026 | 93.233, 93.310, 93.837, 93.838, 93.839, 93.840, 93.847 | |
NHLBI Program Project Applications (P01 Clinical Trials Optional)National Institutes of Health | Closed | Amount not specified | Sep 25, 2026 | 93.233, 93.837, 93.838, 93.839, 93.840 |
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)National Institutes of Health | Closed | Amount not specified | Jan 8, 2026 | 93.121, 93.233, 93.242, 93.279, 93.313, 93.393, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.866 |
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)National Institutes of Health | Closed | Amount not specified | Jan 8, 2026 | 93.121, 93.233, 93.242, 93.279, 93.313, 93.393, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.866 |
93.838 is the Assistance Listing Number for “Lung Diseases Research.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
The SAM.gov listing names these applicant types: For-Profit Organization, Local, Unrestricted by Individual Type, Nonprofit Organization and Not-for-Profit Organization. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
The agency reported $789,408,855 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.